Vaccination

IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study
Frederic A Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skora, Risto Alfredo Perich-Campos, Svetlana A Smakotina, Sergio Cerpa Cruz, Bassem Louzir, Thérèse Croughs, Michael Lucas Tee

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216379; DOI: 10.1136/annrheumdis-2019-216379
Response to: ‘Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares’ by Didierlaurent et al
Chio Yokose, Hyon Choi

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216670; DOI: 10.1136/annrheumdis-2019-216670
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Victoria Furer, Christien Rondaan, Marloes W Heijstek, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Ferry C Breedveld, Raffaele D'Amelio, Maxime Dougados, Meliha Crnkic Kapetanovic, Jacob M van Laar, A de Thurah, Robert BM Landewé, Anna Molto, Ulf Müller-Ladner, Karen Schreiber, Leo Smolar, Jim Walker, Klaus Warnatz, Nico M Wulffraat, Ori Elkayam

Annals of the Rheumatic Diseases Jan 2020, 79 (1) 39-52; DOI: 10.1136/annrheumdis-2019-215882
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares
Arnaud M Didierlaurent, Christophe Desssart, Anthony L Cunningham

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216639; DOI: 10.1136/annrheumdis-2019-216639
Risk of gout flares after vaccination: a prospective case cross-over study
Chio Yokose, Natalie McCormick, Clara Chen, Tuhina Neogi, Christine Chaisson, Robert Terkeltaub, David J Hunter, Yuqing Zhang, Hyon Choi

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1601-1604; DOI: 10.1136/annrheumdis-2019-215724
Risk of gout flares after vaccination
Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

Annals of the Rheumatic Diseases Aug 2019, annrheumdis-2019-216146; DOI: 10.1136/annrheumdis-2019-216146
Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial
Jin Kyun Park, Yunhee Choi, Kevin L Winthrop, Yeong Wook Song, Eun Bong Lee

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1283-1284; DOI: 10.1136/annrheumdis-2019-215187
Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink
Georgina Nakafero, Matthew J Grainge, Puja R Myles, Christian D Mallen, Weiya Zhang, Michael Doherty, Jonathan S Nguyen-Van-Tam, Abhishek Abhishek

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1122-1126; DOI: 10.1136/annrheumdis-2019-215086
Revisiting the issue of how to assess pneumococcal vaccine immunogenicity: a post hoc analysis of antipneumococcal antibody responses among adult patients with systemic lupus erythematosus previously immunised with 23-valent pneumococcal polysaccharide vaccine
Rodrigo Poubel Rezende, Luís Eduardo Coelho Andrade, Evandro Mendes Klumb

Annals of the Rheumatic Diseases Jun 2019, 78 (6) 853-855; DOI: 10.1136/annrheumdis-2018-214888
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al
Giovanni Adami, Angelo Fassio, Giovanni Orsolini, Alessandro Giollo, Davide Gatti, Maurizio Rossini

Annals of the Rheumatic Diseases Feb 2019, annrheumdis-2019-215174; DOI: 10.1136/annrheumdis-2019-215174

Main menu

Vaccination

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Vaccination

Pages